Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
It isn't all about "tinpot",
A fully funded regulatory environment, a streamlined clinical trial process, higher tax incentives for research and European cooperation would all lead to better outcomes for patients.
Boris made a big speech promising change but this Government has delivered nothing.
Enough from me about politics.....back to waiting, as ever. π
All those Brexit Benefits...
Its because tax are a tin pot company with no money
My point being, (before LSE crashed);
A change of Government, with full MHRA and NHS funding restored and a better European relationship (e.g. Horizon), remains our only hope.
Otherwise companies like Valirx will continue to suffer.
Just pop over to SAR and ask for their opinions of the MHRA!!
Ain't happening Fred,
In June 2021 Boris made a speech about restoring Britain as a scientific superpower, exactly the opposite has occurred.
In Nov 21 Valirx signed an LOI with Theoremrx and promised a "transformative year", exactly the opposite has occurred.
https://tinyurl.com/nhjnvtdj
Interesting chat regarding Dame Barbara's cancer...need to reduce cost of getting new drugs approved...change of approach required...use your treatments as an example Val
One post (two now) and three trades. WTF is going on?
Cheers Bob, saved me a job putting the f**kwit right.
Let's not forget the ValiRx mission statement to 'ACCELERATE the development of treatments in cancer and womenβs health to improve patient lives'.
The harsh reality is that they are accelerating absolutely f**k all.
You are telling me. Feels like NNN did in its final days over here. It's Theorem that gets me the most. How can we just carry on like nothing happened, and like no promises were made in terms of updates. Ignore it and it will go away tactics being deployed. The only thing is everyone remembers and nobody will forget.
Somebody from the BOD needs to update the stakeholders.
A CLX timeline:
24 October 22 - Subsidiary launched
06 December 2022 - already commenced a full preclinical development
31 March 2023 - no immediate toxicology concerns
28 September 2023 - Opportunities for early partnering are being explored for Cytolytix, with active commercial development to promote the project to potential industry partners
Hardly, quick.
I couldn't even tell you where this asset is up to now, as the progress appears to be going backwards based on the last quarterly update. Unless the statement about early partnering was a bit of a fib ;-)
You keep giving the excuses though, eh!
pm2022
posts: 2,847
price: 3.45
strong buy
re: some good news today....today 16:28
quick to assume failure. this is drug development not some supermarket where you pick things from the shelf. trial and testing and timings are often over exaggerated.
still very much open could go either way but at this market cap only one success is needed for a multi bagger.
replyrecommendreport post
pm2020 for this your latest well researched , well educated post did you use the same research sources that you used to post buy at 35p++ no brainier with no down side?was it by any chance called recipe for the best bull**** to grow world class mushrooms π€‘π€‘π€‘π€‘ππππ€‘π€‘
Quick to assume failure. This is drug development not some supermarket where you pick things from the shelf. Trial and testing and timings are often over exaggerated.
Still very much open could go either way but at this market cap only one success is needed for a multi bagger.
I'm guessing the further CLX formulations haven't gone that well, considering the quarter referenced is now long gone.
From RNS dated 15th December 2023:
'CLX001 was placed in the single asset subsidiary company, Cytolytix Limited ("Cytolytix") in Q4 2022, and has undergone a programme of formulation development during H1 2023. The peptide active ingredient requires a nanoformulation to ensure that the peptide stabilised within the therapeutic agent and is delivered to cancer cells at appropriate levels.
The formulation development remains challenging, with further formulations being proposed and undergoing testing during the quarter.'
Bring back the mole or is he as dead as this share
Good to see Adrian on the BOD.
Lets hope more good news comes soon!
I'd prefer it if Mr De Courcy would persuade the BOD to pull the pin on Thereom to bring an end to this sorry mess.
It desperately needs to be concluded one way or another. It cannot continue.
Suzy and Kevin didn't have the spine to hold them to account. Let's hope the new leadership team will.
Https://tinyurl.com/47fun5c6
2 tranches of $500,000 via a CLN.
Perhaps De Courcey can persuade Cox to update shareholders.
π
Nookie Bear on the board, a perfect fit...
It's been an uphill struggle but the stage is now set for investors to find out what's actually going on at Valirx. Fingers crossed the wall of silence was just Suzy being bloody minded.
Nice to see Adrian confirmed as a NED. A decent holding, which puts other current members of the BOD to shame.
Neds confirmed
No Luke
ANOTHER EXAMPLE OF SUZY TALKING SH*T*
Apols it is showing
My concern is also Eueda not showing active on Nasdaq.....Its like time has stopped for val and its partners..... apart from the bloody labs....